CardieX Limited (CDX.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 10.1 Million AUD | 173.3% |
| 2023 | 3.69 Million AUD | 18.33% |
| 2022 | 3.12 Million AUD | -23.69% |
| 2021 | 4.09 Million AUD | 13.95% |
| 2020 | 3.59 Million AUD | 15.85% |
| 2019 | 3.1 Million AUD | -0.69% |
| 2018 | 3.12 Million AUD | -5.63% |
| 2017 | 3.31 Million AUD | -16.08% |
| 2016 | 3.94 Million AUD | -13.49% |
| 2015 | 4.56 Million AUD | 10.94% |
| 2014 | 4.11 Million AUD | -47.6% |
| 2013 | 7.84 Million AUD | 43.93% |
| 2012 | 5.44 Million AUD | -14.68% |
| 2011 | 6.38 Million AUD | -22.94% |
| 2010 | 8.28 Million AUD | -12.47% |
| 2009 | 9.46 Million AUD | 83.35% |
| 2008 | 5.16 Million AUD | 33.69% |
| 2007 | 3.86 Million AUD | 63.06% |
| 2006 | 2.36 Million AUD | 6.04% |
| 2005 | 2.23 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 989.33 Thousand AUD | -77.16% |
| 2024 Q4 | 989.33 Thousand AUD | 0.0% |
| 2024 Q2 | 4.33 Million AUD | -13.68% |
| 2024 FY | 155.96 Thousand AUD | -95.78% |
| 2024 Q1 | 5.01 Million AUD | 229.94% |
| 2023 FY | 3.69 Million AUD | 18.33% |
| 2023 Q4 | -3.86 Million AUD | -340.81% |
| 2023 Q2 | -4.38 Million AUD | -656.01% |
| 2023 Q1 | 788.88 Thousand AUD | 121.33% |
| 2023 Q3 | 1.6 Million AUD | 136.56% |
| 2022 FY | 3.12 Million AUD | -23.69% |
| 2022 Q4 | -3.69 Million AUD | -499.81% |
| 2022 Q3 | 924.84 Thousand AUD | 130.71% |
| 2022 Q2 | -3.01 Million AUD | -420.13% |
| 2022 Q1 | 940.81 Thousand AUD | 141.0% |
| 2021 Q2 | -238.03 Thousand AUD | -119.35% |
| 2021 Q1 | 1.23 Million AUD | -30.68% |
| 2021 Q4 | -2.29 Million AUD | -310.64% |
| 2021 Q3 | 1.08 Million AUD | 557.66% |
| 2021 FY | 4.09 Million AUD | 13.95% |
| 2020 Q2 | 1.81 Million AUD | 74.89% |
| 2020 FY | 3.59 Million AUD | 15.85% |
| 2020 Q4 | 1.77 Million AUD | 77.54% |
| 2020 Q3 | 999.49 Thousand AUD | -45.08% |
| 2020 Q1 | 1.04 Million AUD | -37.15% |
| 2019 Q2 | 975.28 Thousand AUD | -0.0% |
| 2019 Q4 | 1.65 Million AUD | 71.72% |
| 2019 FY | 3.1 Million AUD | -0.69% |
| 2019 Q1 | 975.28 Thousand AUD | 18.27% |
| 2019 Q3 | 964.13 Thousand AUD | -1.14% |
| 2018 Q4 | 824.64 Thousand AUD | 0.0% |
| 2018 Q3 | 824.64 Thousand AUD | -14.41% |
| 2018 FY | 3.12 Million AUD | -5.63% |
| 2018 Q2 | 963.45 Thousand AUD | 0.0% |
| 2018 Q1 | 963.45 Thousand AUD | -20.15% |
| 2017 FY | 3.31 Million AUD | -16.08% |
| 2017 Q2 | 685.29 Thousand AUD | -0.0% |
| 2017 Q1 | 685.29 Thousand AUD | -48.8% |
| 2017 Q4 | 1.2 Million AUD | 0.0% |
| 2017 Q3 | 1.2 Million AUD | 76.07% |
| 2016 Q3 | 1.33 Million AUD | 111.14% |
| 2016 Q4 | 1.33 Million AUD | 0.0% |
| 2016 Q2 | 633.97 Thousand AUD | 0.0% |
| 2016 Q1 | 633.97 Thousand AUD | -40.82% |
| 2016 FY | 3.94 Million AUD | -13.49% |
| 2015 FY | 4.56 Million AUD | 10.94% |
| 2015 Q4 | 1.07 Million AUD | 0.0% |
| 2015 Q3 | 1.07 Million AUD | -11.38% |
| 2015 Q2 | 1.2 Million AUD | 0.0% |
| 2015 Q1 | 1.2 Million AUD | 26.03% |
| 2014 Q4 | 959.15 Thousand AUD | 0.0% |
| 2014 Q1 | 1.09 Million AUD | -28.52% |
| 2014 FY | 4.11 Million AUD | -47.6% |
| 2014 Q2 | 1.09 Million AUD | 0.0% |
| 2014 Q3 | 959.15 Thousand AUD | -12.49% |
| 2013 Q3 | 1.53 Million AUD | -35.8% |
| 2013 Q2 | 2.38 Million AUD | 0.0% |
| 2013 Q4 | 1.53 Million AUD | 0.0% |
| 2013 FY | 7.84 Million AUD | 43.93% |
| 2013 Q1 | 2.38 Million AUD | 75.31% |
| 2012 Q2 | 1.36 Million AUD | -14.68% |
| 2012 Q4 | 1.36 Million AUD | 0.0% |
| 2012 Q3 | 1.36 Million AUD | 0.0% |
| 2012 Q1 | 1.59 Million AUD | 0.0% |
| 2012 FY | 5.44 Million AUD | -14.68% |
| 2011 Q1 | 2.07 Million AUD | 0.0% |
| 2011 Q4 | 1.59 Million AUD | 0.0% |
| 2011 FY | 6.38 Million AUD | -22.94% |
| 2011 Q3 | 1.59 Million AUD | 0.0% |
| 2011 Q2 | 1.59 Million AUD | -22.94% |
| 2010 Q2 | 2.07 Million AUD | -12.47% |
| 2010 Q3 | 2.07 Million AUD | 0.0% |
| 2010 Q1 | 2.36 Million AUD | 0.0% |
| 2010 FY | 8.28 Million AUD | -12.47% |
| 2010 Q4 | 2.07 Million AUD | 0.0% |
| 2009 Q2 | 2.36 Million AUD | 83.35% |
| 2009 Q4 | 2.36 Million AUD | 0.0% |
| 2009 Q1 | 1.29 Million AUD | 0.0% |
| 2009 Q3 | 2.36 Million AUD | 0.0% |
| 2009 FY | 9.46 Million AUD | 83.35% |
| 2008 Q1 | 965.75 Thousand AUD | 0.0% |
| 2008 Q2 | 1.29 Million AUD | 33.69% |
| 2008 Q3 | 1.29 Million AUD | 0.0% |
| 2008 FY | 5.16 Million AUD | 33.69% |
| 2008 Q4 | 1.29 Million AUD | 0.0% |
| 2007 Q2 | 965.75 Thousand AUD | 63.06% |
| 2007 Q3 | 965.75 Thousand AUD | 0.0% |
| 2007 Q4 | 965.75 Thousand AUD | 0.0% |
| 2007 FY | 3.86 Million AUD | 63.06% |
| 2007 Q1 | 592.25 Thousand AUD | 0.0% |
| 2006 Q3 | 592.25 Thousand AUD | 0.0% |
| 2006 Q1 | 558.5 Thousand AUD | 0.0% |
| 2006 FY | 2.36 Million AUD | 6.04% |
| 2006 Q2 | 592.25 Thousand AUD | 6.04% |
| 2006 Q4 | 592.25 Thousand AUD | 0.0% |
| 2005 Q4 | 558.5 Thousand AUD | 0.0% |
| 2005 Q2 | 558.5 Thousand AUD | 0.0% |
| 2005 FY | 2.23 Million AUD | 0.0% |
| 2005 Q3 | 558.5 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | -187.353% |
| Adherium Limited | -640.83 Thousand AUD | 1677.28% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 81.278% |
| Atomo Diagnostics Limited | 1.43 Million AUD | -603.538% |
| Anteris Technologies Ltd | 2.51 Million AUD | -301.551% |
| Control Bionics Limited | 3.67 Million AUD | -175.208% |
| Compumedics Limited | 26.06 Million AUD | 61.225% |
| Cochlear Limited | 1.69 Billion AUD | 99.404% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 11.018% |
| Cyclopharm Limited | 4.49 Million AUD | -124.75% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 9.907% |
| Nova Eye Medical Limited | 20.19 Million AUD | 49.944% |
| HeraMED Limited | -504.09 Thousand AUD | 2105.131% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 607.191% |
| ImpediMed Limited | 9 Million AUD | -12.246% |
| InhaleRx Limited | 1.2 Million AUD | -739.483% |
| LBT Innovations Limited | -2.91 Million AUD | 446.512% |
| Micro-X Limited | 5.73 Million AUD | -76.186% |
| Neurotech International Limited | -5867.00 AUD | 172381.626% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -18068.973% |
| PolyNovo Limited | 36.08 Million AUD | 71.989% |
| Respiri Limited | 456.91 Thousand AUD | -2112.181% |
| SomnoMed Limited | 55.13 Million AUD | 81.666% |
| Universal Biosensors, Inc. | 4.28 Million AUD | -135.891% |
| Uscom Limited | 3.11 Million AUD | -224.414% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 3828.206% |